VCBeat Health Contact Us
Home Dr. Li Changqing Appointed Chief Medical Officer at Evergreen Therapeutics to Lead Global Drug Development

Dr. Li Changqing Appointed Chief Medical Officer at Evergreen Therapeutics to Lead Global Drug Development

Jul 22, 2021 09:44 CST Updated 09:44
Evergreen Therapeutics

Innovative Drug Developer

On July 19, 2021, Evergreen Therapeutics announced the appointment of Dr. Changqing Li as Chief Medical Officer (CMO), to oversee the company's global new drug development efforts.

*Disclaimer: This article was written by a contributing author to Sina Medical News. The views expressed are solely those of the author and do not represent the position of Sina Medical News.